Guard Therapeutics International AB Capital Reinvestment Ratio

Latest as of March 2015: 2.37x

Guard Therapeutics International AB capital reinvestment ratio. Guard Therapeutics International AB (GUARD) has a Capital Reinvestment Ratio of 2.37x as of March 2015, meaning it reinvests 2% of its operating cash flow (Skr1.16 Million) in capital expenditures (Skr2.75 Million). Check GUARD cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

2.37x

Capex / Operating Cash Flow

Operating Cash Flow

Skr1.16 Million

SEK

Capital Expenditures

Skr2.75 Million

SEK

Data as of

Mar 2015

Most recent filing

Guard Therapeutics International AB Capital Reinvestment Ratio by Year (None–None)

Guard Therapeutics International AB capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Guard Therapeutics International AB cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow